Association for the Accreditation of Human Research Protection Programs

Association for the Accreditation of Human Research Protection Programs is a nonprofit accreditation body established to improve the quality of protections for human subjects in research through voluntary accreditation of institutions that conduct or review research. The organization interacts with institutions, oversight bodies, and regulatory frameworks while engaging stakeholders across academic, clinical, and corporate research sectors.

History

The organization was founded in 2001 amid efforts following high-profile controversies such as Tuskegee syphilis experiment, regulatory responses including the Common Rule revisions, and heightened oversight from agencies like the Food and Drug Administration and the National Institutes of Health. Early collaborators included academic institutions such as Johns Hopkins University, healthcare systems like Mayo Clinic, and research sponsors such as Pfizer and GlaxoSmithKline, seeking an external mechanism analogous to Joint Commission accreditation and international standards exemplified by International Organization for Standardization frameworks. Over time the organization expanded scope parallel to changes in policy influenced by events including the Helsinki Declaration debates and guidance from bodies like the World Health Organization and the Council for International Organizations of Medical Sciences.

Purpose and Standards

The stated purpose is to enhance protection for participants in clinical trials and behavioral studies while promoting consistency in institutional practices akin to accreditation models used by American College of Surgeons and certification schemes such as those from National Committee for Quality Assurance. Standards address responsibilities comparable to oversight described in statutes like the Food, Drug, and Cosmetic Act and directives from Office for Human Research Protections as well as best practices promoted by organizations such as Association of American Medical Colleges and American Medical Association. Criteria cover institutional policies, institutional review board processes similar to procedures at Massachusetts General Hospital IRB offices, consent processes referenced in cases like Moore v. Regents of the University of California, and protections for vulnerable populations addressed in guidance from UNICEF and United Nations conventions.

Accreditation Process

The accreditation process comprises an application phase, a document review reminiscent of peer review at journals like The New England Journal of Medicine and The Lancet, and on-site evaluation teams parallel to inspection practices by Centers for Medicare & Medicaid Services surveyors. Applicants must demonstrate alignment with standards comparable to those employed by American Society of Clinical Oncology programs and may be required to show compliance with regulations by European Medicines Agency for multinational trials. Decisions follow consensus models used by bodies such as National Academies of Sciences, Engineering, and Medicine panels, and accredited status is maintained through periodic re-evaluation modeled on cycles used by the College of American Pathologists.

Governance and Funding

Governance is conducted through a board of directors and advisory committees reflecting stakeholder representation similar to governance practices at institutions like University of California systems and nonprofits such as American Red Cross. Funding sources historically include fees from applicant institutions, grants from foundations akin to those awarded by the Gates Foundation or Robert Wood Johnson Foundation, and contracts with governmental entities analogous to agreements with Department of Health and Human Services. Conflicts of interest and transparency measures are managed using policies inspired by standards at American Bar Association and disclosure practices recommended by Transparency International.

Impact and Criticism

Proponents cite improvements in institutional review processes at hospitals and universities comparable to quality gains reported by Cleveland Clinic and Stanford University, claiming enhanced participant protections and harmonization with international regulators like Health Canada. Criticisms mirror debates faced by accrediting entities such as Council on Accreditation and focus on costs for smaller institutions, potential redundancy with regulatory inspections from Office for Human Research Protections and Food and Drug Administration, and questions about evidence for impact similar to critiques of accreditation in Higher education accreditation contexts. Academic analyses published in venues such as JAMA and BMJ have examined effectiveness, while policy discussions have engaged stakeholders including Congressional Research Service briefings and advisory input from National Institutes of Health working groups.

Category:Research ethics Category:Medical and health organizations